Clinical Trial Update: [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating [18F]Fluciclovine and [18F]FLT PET/CT imaging in primary high-grade brain tumors; the trial is terminated and results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Axumin (fluciclovine F-18) (fluciclovine F-18)
• FLT PET tracer (fluorothymidine F-18) (fluorothymidine F-18)

Snippet

Sponsor: University of Utah | Conditions: Brain Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-12-27